Virginia attracted $12 billion in pharmaceutical manufacturing investments in 2025, leveraging site readiness, workforce training, and strong infrastructure.
Proven asset-light model continues to deliver scalable, high-return growth through manachised and franchised hotels that require minimal capital while generating stable royalty and management fee ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results